156 related articles for article (PubMed ID: 7990116)
41. Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3 beta-(3'-substituted phenyl)-, 3 beta-(4'-substituted phenyl)-, and 3 beta-(3',4'-disubstituted phenyl)tropane-2 beta-carboxylic acid methyl esters.
Carroll FI; Mascarella SW; Kuzemko MA; Gao Y; Abraham P; Lewin AH; Boja JW; Kuhar MJ
J Med Chem; 1994 Sep; 37(18):2865-73. PubMed ID: 8071935
[TBL] [Abstract][Full Text] [Related]
42. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor.
Hanson RN; Napolitano E; Fiaschi R
J Med Chem; 1998 Nov; 41(24):4686-92. PubMed ID: 9822539
[TBL] [Abstract][Full Text] [Related]
44. Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules.
Waller CL; Marshall GR
J Med Chem; 1993 Aug; 36(16):2390-403. PubMed ID: 8360884
[TBL] [Abstract][Full Text] [Related]
45. 3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA.
Ashek A; Lee C; Park H; Cho SJ
Chemosphere; 2006 Oct; 65(3):521-9. PubMed ID: 16487571
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17 alpha, 20E)- and (17 alpha, 20Z)-21-halo-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols.
Napolitano E; Fiaschi R; Hanson RN
J Med Chem; 1991 Sep; 34(9):2754-9. PubMed ID: 1895295
[TBL] [Abstract][Full Text] [Related]
47. 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.
Gohlke H; Schwarz S; Gündisch D; Tilotta MC; Weber A; Wegge T; Seitz G
J Med Chem; 2003 May; 46(11):2031-48. PubMed ID: 12747776
[TBL] [Abstract][Full Text] [Related]
48. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
49. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization.
Waller CL; McKinney JD
Chem Res Toxicol; 1995 Sep; 8(6):847-58. PubMed ID: 7492734
[TBL] [Abstract][Full Text] [Related]
50. 2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore.
Carrieri A; Brasili L; Leonetti F; Pigini M; Giannella M; Bousquet P; Carotti A
Bioorg Med Chem; 1997 May; 5(5):843-56. PubMed ID: 9208096
[TBL] [Abstract][Full Text] [Related]
51. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor.
Hong H; Fang H; Xie Q; Perkins R; Sheehan DM; Tong W
SAR QSAR Environ Res; 2003; 14(5-6):373-88. PubMed ID: 14758981
[TBL] [Abstract][Full Text] [Related]
52. 3D-QSAR analysis of conformationally constrained diacylglycerol (DAG) analogues as potent protein kinase C (PK-C) ligands.
Kim SY; Lee J
Bioorg Med Chem; 2004 May; 12(10):2639-44. PubMed ID: 15110845
[TBL] [Abstract][Full Text] [Related]
53. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
[TBL] [Abstract][Full Text] [Related]
54. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
Raghavan K; Buolamwini JK; Fesen MR; Pommier Y; Kohn KW; Weinstein JN
J Med Chem; 1995 Mar; 38(6):890-7. PubMed ID: 7699704
[TBL] [Abstract][Full Text] [Related]
55. Ligand-based identification of environmental estrogens.
Waller CL; Oprea TI; Chae K; Park HK; Korach KS; Laws SC; Wiese TE; Kelce WR; Gray LE
Chem Res Toxicol; 1996 Dec; 9(8):1240-8. PubMed ID: 8951225
[TBL] [Abstract][Full Text] [Related]
56. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
[TBL] [Abstract][Full Text] [Related]
57. Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.
el Amouri H; Vessières A; Vichard D; Top S; Gruselle M; Jaouen G
J Med Chem; 1992 Aug; 35(17):3130-5. PubMed ID: 1507201
[TBL] [Abstract][Full Text] [Related]
58. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
59. How good are ensembles in improving QSAR models? The case with eCoRIA.
Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
[TBL] [Abstract][Full Text] [Related]
60. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
